IL1RL1 and atherosclerosis: IL-33 and its receptor ST2 are associated with a variety of inflammatory diseases, such as asthma, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, and cardiovascular disease including atherosclerosis [13].